IMFINZI

Concentrate for solution for infusion, 50mg/ml
RxActive license

Active substance (INN)

durvalumab

Pharmaceutical form

Pharmaceutical formConcentrate for solution for infusion
Strength50mg/ml
PackagingUkupno 1 bočica staklena sa 10ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerAstraZeneca AB, Sweden
Therapeutic groupAntineoplastic and immunomodulating agents (L01FF03)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateOctober 8, 2020

Analogs in Montenegro

1

Other medicines with the same active substance

IMFINZIRx
Concentrate for solution for infusion, 50mg/mlAstraZeneca AB
Source: CInMED register